Clinical Trial Update: Safety of Sabin Inactivated Poliovirus Vaccine in Adults, Children and Infants and Lot Consistency Immunogenicity, and Safety of the msIPV in 2 Months Old Infants [Phase 3]

View source ↗

Summary

Phase 3 trial update on safety and lot consistency immunogenicity of Sabin inactivated poliovirus vaccine (sIPV) in adults, children, infants, and msIPV in 2-mo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Poliomyelitis

Drugs mentioned

• Sabin Inactivated Poliovirus Vaccine (inactivated poliovirus vaccine (Sabin strain))

Snippet

Sponsor: Sinovac Biotech Co., Ltd | Conditions: Poliomyelitis | Phase 3 | Status: COMPLETED